We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+40.48%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$565M
AUM Growth
+$183M
Cap. Flow
+$64.7M
Cap. Flow %
11.44%
Top 10 Hldgs %
66.34%
Holding
79
New
22
Increased
9
Reduced
6
Closed
5
Avg Time Held
0.3 years
Top 10 Avg Time Held
0.4 years
Top 20 Avg Time Held
0.4 years

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$55.2M
2
EOSE icon
Eos Energy Enterprises
EOSE
+$5.07M
3
LIQT icon
LiqTech
LIQT
+$4.94M
4
LSXMA icon
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
+$3.45M
5
FATE icon
Fate Therapeutics
FATE
+$2.39M

Top Sells

Rank Stock Value
1
WELL icon
Welltower
WELL
+$6.7M
2
FLNA icon
Filana Therapeutics
FLNA
+$3.13M
3
PYPL icon
PayPal
PYPL
+$2.42M
4
IHC
Independence Holding Company
IHC
+$1.12M
5
RTN
Raytheon Company
RTN
+$566K

Sector Composition

Rank Sector Weight
1 Healthcare 28.61%
2 Industrials 14.54%
3 Miscellaneous 14.26%
4 Energy 11.06%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RTX icon
51
RTX Corp
RTX
$252B
$370K 0.07%
+6,000
New +$374K
2020 Q2
0 quarters
XFOR icon
52
X4 Pharmaceuticals
XFOR
$253M
$333K 0.06%
1,191
– –
2019 Q4
2 quarters
LHX icon
53
L3Harris
LHX
$44.7B
$271K 0.05%
1,600
– –
2019 Q4
2 quarters
VATE icon
54
INNOVATE Corp
VATE
$84M
$239K 0.04%
7,154
– –
2020 Q1
1 quarter
INFI
55
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$226K 0.04%
250,000
-250,000
-50% -$238K
2019 Q4
2 quarters
BATRA icon
56
Atlanta Braves Holdings Series A
BATRA
$3.55B
$208K 0.04%
10,356
– –
2019 Q4
2 quarters
PHYS icon
57
Sprott Physical Gold
PHYS
$14.9B
$179K 0.03%
12,540
– –
2019 Q4
2 quarters
OTIS icon
58
Otis Worldwide
OTIS
$26.6B
$171K 0.03%
+3,000
New +$155K
2020 Q2
0 quarters
CARR icon
59
Carrier Global
CARR
$45.1B
$133K 0.02%
+6,000
New +$111K
2020 Q2
0 quarters
LILAK icon
60
Liberty Latin America Class C
LILAK
$1.61B
$115K 0.02%
+14,212
New +$121K
2020 Q2
0 quarters
LGF.B
61
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$112K 0.02%
16,413
– –
2019 Q4
2 quarters
BNY icon
62
Bank of New York Mellon
BNY
$95.5B
$77K 0.01%
2,000
– –
2020 Q1
1 quarter
LITE icon
63
Lumentum
LITE
$77.9B
$54K 0.01%
+660
New +$50.3K
2020 Q2
0 quarters
XLNX
64
DELISTED
Xilinx Inc
XLNX
$52K 0.01%
+530
New +$47K
2020 Q2
0 quarters
ABBV icon
65
AbbVie
ABBV
$509B
$51K 0.01%
+515
New +$45.3K
2020 Q2
0 quarters
TER icon
66
Teradyne
TER
$53B
$51K 0.01%
+600
New +$40.2K
2020 Q2
0 quarters
CDNS icon
67
Cadence Design Systems
CDNS
$89B
$50K 0.01%
+525
New +$43.9K
2020 Q2
0 quarters
T icon
68
AT&T
T
$163B
$50K 0.01%
+2,185
New +$49.8K
2020 Q2
0 quarters
XOM icon
69
ExxonMobil
XOM
$719B
$48K 0.01%
+1,075
New +$48.2K
2020 Q2
0 quarters
MO icon
70
Altria Group
MO
$123B
$47K 0.01%
+1,200
New +$46.8K
2020 Q2
0 quarters
LILA icon
71
Liberty Latin America Class A
LILA
$1.62B
$39K 0.01%
6,274
– –
2020 Q1
1 quarter
PRGX
72
DELISTED
PRGX Global, Inc.
PRGX
$37K 0.01%
+7,938
New +$28.5K
2020 Q2
0 quarters
ADEA icon
73
Adeia
ADEA
$2.34B
$1K ﹤0.01%
+340
New +$1.29K
2020 Q2
0 quarters
AVNW icon
74
Aviat Networks
AVNW
$249M
$1K ﹤0.01%
+66
New +$412
2020 Q2
0 quarters
MTB icon
75
M&T Bank
MTB
$31.5B
– –
-5,274
Closed -$545K –
1 2
3
4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q2 2020 Portfolio in Review

As of Q2 2020, Bleichroeder LP held 79 positions worth $565M, up 48% from $383M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bleichroeder LP deployed $64.7M of net new capital in Q2 2020, opening 22 new positions and adding to 9 existing holdings. Its largest new stake was Royalty Pharma: 1,115,980 shares worth $54.2M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 20% a quarter earlier, followed by Industrials and Miscellaneous.

On the sell side, the largest reduction was Filana Therapeutics, an estimated $3.13M trimmed.

  • Bleichroeder LP's largest Q2 2020 buy was Royalty Pharma: 1,115,980 shares worth $54.2M.
  • Bleichroeder LP added most to LiqTech in Q2 2020, an estimated $4.94M increase.
  • Bleichroeder LP's biggest Q2 2020 reduction was Filana Therapeutics, cutting an estimated $3.13M.
  • Bleichroeder LP fully exited Welltower in Q2 2020, selling an estimated $6.7M.
  • Bleichroeder LP's ten largest holdings make up 66% of its $565M portfolio in Q2 2020.
  • Bleichroeder LP opened 22 new positions and closed 5 in Q2 2020.
  • Bleichroeder LP's portfolio value rose 48% quarter-over-quarter to $565M.

Based on Bleichroeder LP's 13F filing for Q2 2020, filed 12 Aug 2020.